| Clinical outcomes and toxic effects of single-agent immune checkpoint inhibitors among patients aged 80 years or older with cancer: a multicenter international cohort study CA Nebhan, A Cortellini, W Ma, T Ganta, H Song, F Ye, R Irlmeier, ... JAMA oncology 7 (12), 1856-1861, 2021 | 98 | 2021 |
| The RNA‐binding protein Musashi 1 stabilizes the oncotachykinin 1 mRNA in breast cancer cells to promote cell growth GR Nahas, RG Murthy, SA Patel, T Ganta, SJ Greco, P Rameshwar The FASEB Journal 30 (1), 149-159, 2016 | 34 | 2016 |
| Role of α-and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease M Archer, N Dogra, Z Dovey, T Ganta, HS Jang, JA Khusid, A Lantz, ... Cell Communication and Signaling 19, 1-21, 2021 | 24 | 2021 |
| Patient portal access for caregivers of adult and geriatric patients: reframing the ethics of digital patient communication T Ganta, JM Appel, N Genes Journal of Medical Ethics 49 (3), 156-159, 2023 | 7 | 2023 |
| Is reduction of tumor burden sufficient for the 21st century? G Nahas, SA Bliss, G Sinha, T Ganta, SJ Greco, P Rameshwar Cancer Letters 356 (2), 149-155, 2015 | 3 | 2015 |
| Smoking status and immunotherapy outcomes in smoking-associated cancers. T Jun, T Ganta, Q Qin, VG Patel, B Wang, G Mellgard, ... Journal of Clinical Oncology 38 (15_suppl), e15097-e15097, 2020 | 2 | 2020 |
| Tumor Lysis Syndrome After Bilobectomy for Typical Carcinoid Tumor of the Lung TH Shin, E Inagaki, T Ganta, K Hartshorn, VR Litle, K Suzuki The Annals of Thoracic Surgery 107 (3), e199-e201, 2019 | 2 | 2019 |
| Safety and Efficacy Outcomes of Early Cessation of Anti-PD1 Therapy in Patients 80 Years or Older: A Retrospective Cohort Study K Fletcher, A Cortellini, T Ganta, R Kankaria, H Song, F Ye, R Irlmeier, ... Cancer Letters, 217001, 2024 | 1 | 2024 |
| Effect of adrenergic receptor antagonists on clinical outcomes in metastatic renal cell carcinoma. T Ganta, CK Tsao Journal of Clinical Oncology 40 (16_suppl), e16520-e16520, 2022 | 1 | 2022 |
| Fairness in Predicting Cancer Mortality Across Racial Subgroups T Ganta, A Kia, P Parchure, M Wang, M Besculides, M Mazumdar, ... JAMA Network Open 7 (7), e2421290-e2421290, 2024 | | 2024 |
| Characterizing the authorship of phase 3 randomized clinical trials in oncology, 1960-2023. JL Warner, BR Bakow, AJ Brown, JH Choe, E Fan, T Ganta, M Glover, ... Journal of Clinical Oncology 42 (16_suppl), 11079-11079, 2024 | | 2024 |
| Evaluation of the study of control arms in randomized clinical trials of cancer. SK Jain, MG Zauderer, T Sethi, MW Schoen, S Rubinstein, RHT Nguyen, ... Journal of Clinical Oncology 42 (16_suppl), 11023-11023, 2024 | | 2024 |
| Palliative Care Consultations for Older Adult Hospitalized with Cancer at the End of Life K Parsa, E Elias, T Ganta, A Khazak, T Sheng, CB Smith Journal of Pain and Symptom Management 67 (5), e722, 2024 | | 2024 |
| Real world utilization and outcomes of immunotherapy regimens in metastatic castration resistant prostate cancer (mCRPC). T Ganta, JF Anker, EJ Miller, K Tsao, WK Oh Journal of Clinical Oncology 41 (16_suppl), e17038-e17038, 2023 | | 2023 |
| Local and systemic therapies for renal cell carcinoma with brain metastases: A single-institution series. T Ganta, EJ Miller, JF Anker, MD Galsky, K Tsao Journal of Clinical Oncology 41 (6_suppl), 627-627, 2023 | | 2023 |
| Oncologist-driven development of an electronic health record (EHR) clinical data visualization tool for prostate cancer. T Ganta, JF Anker, EJ Miller, J Kannry, AS Bhardwaj, K Tsao, WK Oh Journal of Clinical Oncology 41 (6_suppl), 267-267, 2023 | | 2023 |
| Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer TY Chen, M Mihalopoulos, L Zuluaga, J Rich, T Ganta, R Mehrazin, ... International Journal of Molecular Sciences 24 (19), 14713, 2023 | | 2023 |
| Human-centered design to improve clinical decision support systems (CDSS) to engage in serious illness communication (SIC) with patients with cancer in a gastrointestinal … T Ganta, S Lehrman, I Durkovic, J Royer, B Tsembelis, M Liu, R Freeman, ... Journal of Clinical Oncology 40 (28_suppl), 433-433, 2022 | | 2022 |
| Acceptability of a machine learning-powered clinical decision support system aiding serious illness conversation and its impact on clinical outcomes: A pilot study. T Ganta, S Lehrman, R Pappalardo, I Durkovic, S Lichtman, B Tsembelis, ... Journal of Clinical Oncology 40 (16_suppl), 6562-6562, 2022 | | 2022 |
| Defining an Ethical Relationship with Artificial Intelligence at a Large Academic Health System. T Ganta, N Genes, BS Glicksberg, R Rhodes, R Freeman, B Darrow AMIA, 2022 | | 2022 |
Natasha KyprianouProfessor of Urology, Oncological Sciences and Pathology, Icahn School of Medicine at Mount Sinai在 mountsinai.org 的电子邮件经过验证
